Tested across 541 biopsy-proven patients with NAFLD, FIB-4 demonstrated significantly superior diagnostic accuracy than AST/ALT ratio, APRI, BARD score, Goteborg University Cirrhosis Index, and cirrhosis discriminant score. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.